ROLE OF CYTOCHROME P4502E1 IN ALCOHOLIC LIVER-DISEASE PATHOGENESIS

被引:134
|
作者
MORIMOTO, M
HAGBJORK, AL
NANJI, AA
INGELMANSUNDBERG, M
LINDROS, KO
FU, PC
ALBANO, E
FRENCH, SW
机构
[1] UCLA,HARBOR MED CTR,DEPT PATHOL,TORRANCE,CA 90509
[2] KAROLINSKA INST,DEPT PHYSIOL CHEM,S-10401 STOCKHOLM,SWEDEN
[3] NEW ENGLAND DEACONESS HOSP,DEPT PATHOL,BOSTON,MA 02215
[4] HARVARD UNIV,SCH MED,BOSTON,MA
[5] STATE ALCOHOL MONOPOLY,RES LABS,HELSINKI,FINLAND
[6] UNIV TORINO,DEPT EXPTL MED & ONCOL,TURIN,ITALY
关键词
ALD MODEL; LIPID PEROXIDATION; PUFA; FATTY ACID; LINOLEIC ACID; PROTEIN ADDUCTS; DIALLYL SULFIDE; CYTOCHROME P4502E1;
D O I
10.1016/0741-8329(93)90065-V
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
The intragastric tube feeding model is ideal for the study of the role of dietary factors and the effect of drugs on experimental alcoholic liver disease (ALD), since the model allows us to study the effect of a single variable in the diet on the pathology of liver where the blood alcohol level (BAL) is maintained over 150 mg%. By varying the dietary fatty acid composition we showed that the pathology was worsened by increasing linoleic acid or polyunsaturated fatty acids (PUFAs) in the diet where cytochrome P4502E1 (CYP2E1) was increased posttranslationally by high BAL. Concomitant with the increase in CYP2E1 there was evidence for an increase in lipid peroxidation (LP) by microsomes. Protein adducts of the products of LP were increased in the blood. Isoniazid (INH) enhanced this process and the pathology of ALD when INH was fed at therapeutic levels with ethanol. Preliminary studies show that diallyl sulfide, which inhibits and destroys liver CYP2E1 selectively, also modified the pathologic effects of ethanol. Thus we postulate that CYP2E1 induction plays a central role in the pathogenesis of ALD.
引用
收藏
页码:459 / 464
页数:6
相关论文
共 50 条
  • [1] The role of cytochrome P4502E1 in the pathogenesis of alcoholic liver disease and carcinogenesis
    Seitz, Helmut K.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2020, 316
  • [2] GENETIC POLYMORPHISMS OF CYTOCHROME P4502E1 RELATED TO THE DEVELOPMENT OF ALCOHOLIC LIVER-DISEASE
    TSUTSUMI, M
    TAKADA, A
    WANG, JS
    GASTROENTEROLOGY, 1994, 107 (05) : 1430 - 1435
  • [3] Cytochrome P4502E1 and cytokines in Alcoholic Liver Disease.
    Ingelman-Sundberg, M
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (08) : 54A - 54A
  • [4] Innate immunity and cell death in alcoholic liver disease: Role of cytochrome P4502E1
    Barnes, Mark A.
    Roychowdhury, Sanjoy
    Nagy, Laura E.
    REDOX BIOLOGY, 2014, 2 : 929 - 935
  • [5] CYTOCHROME P4502E1 AS A DRIVING FORCE IN THE PROGRESSION OF ALCOHOLIC LIVER DISEASE
    Seitz, H. K.
    Qin, H.
    Glassen, K.
    Waldherr, R.
    Flechtenmacher, C.
    Millonig, G.
    Peccerella, T.
    Stickel, F.
    Schirmacher, P.
    Bruckner, T.
    Mueller, S.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S763 - S763
  • [6] THE ROLE OF CYTOCHROME P4502E1 (CYP2E1) IN THE PROGRESSION OF ALCOHOLIC LIVER DISEASE
    Seitz, H. K.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 36 : 26A - 26A
  • [7] Genetic polymorphism of cytochrome P4502E1 and risk of alcoholic liver disease in Caucasians
    Pirmohamed, M
    Kitteringham, NR
    Quest, LJ
    Allott, RL
    Green, VJ
    Gilmore, IT
    Park, BK
    PHARMACOGENETICS, 1995, 5 (06): : 351 - 357
  • [8] Inhibition of cytochrome P4502E1 improves alcoholic liver disease: A possible strategy for intervention
    Seitz, H. K.
    Hohmann, N.
    Mueller, S.
    Haefeli, W. E.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 46 : 41 - 42
  • [9] Cytochrome P4502E1 and alcoholic liver disease: A success story from bench to bedside
    Seitz, H. K.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 46 : 19 - 20
  • [10] The role of Cytochrom P4502E1 in Alcoholic Liver Disease and alcohol mediated carcinogenesis
    Seitz, Helmut Karl
    Mueller, Sebastian
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (01): : 37 - 45